Vertex Pharmaceuticals (VRTX) Insider Trading & Ownership → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free VRTX Stock Alerts $397.48 -0.22 (-0.06%) (As of 04/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Vertex Pharmaceuticals (NASDAQ:VRTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage0.20%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)12Amount OfInsider Selling(Last 12 Months)$41.40 M Get VRTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Vertex Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address VRTX Insider Buying and Selling by Quarter Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. Vertex Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/26/2024Ourania TatsisEVPSell354$425.70$150,697.80 2/20/2024Ourania TatsisEVPSell480$420.79$201,979.20 2/12/2024Amit SachdevEVPSell3,222$420.24$1,354,013.28 2/12/2024Jeffrey M LeidenChairmanSell2,656$419.51$1,114,218.56 2/12/2024Kristen AmbroseCAOSell1,374$420.24$577,409.76 2/12/2024Stuart A ArbuckleCOOSell4,295$420.24$1,804,930.80 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/8/2024Jeffrey M LeidenChairmanSell6,648$419.07$2,785,977.36 11/6/2023Bruce I SachsDirectorSell11,250$385.00$4,331,250.00 10/31/2023Carmen BozicCMOSell5,651$355.92$2,011,303.92 10/24/2023Greg StantonU.S. Congress Member (D-AZ)Sell$369.38$1,001 - $15,00010/17/2023Carmen BozicCMOSell5,651$373.25$2,109,235.75 10/17/2023Sangeeta N BhatiaDirectorSell243$375.00$91,125.00 10/16/2023Jeffrey M LeidenChairmanSell12,962$374.00$4,847,788.00 10/6/2023Sangeeta N BhatiaDirectorSell242$360.00$87,120.00 10/3/2023Carmen BozicCMOSell5,651$345.28$1,951,177.28 10/2/2023Jonathan BillerEVPSell610$346.76$211,523.60 9/19/2023Carmen BozicCMOSell5,651$351.00$1,983,501.00 8/23/2023Ourania TatsisEVPSell2,500$355.00$887,500.00 8/9/2023David AltshulerEVPSell63$345.51$21,767.13 8/9/2023Sangeeta N BhatiaDirectorSell242$345.51$83,613.42 7/17/2023Bruce I SachsDirectorSell11,250$356.75$4,013,437.50 7/17/2023Reshma KewalramaniCEOSell7,828$355.00$2,778,940.00 6/15/2023Stuart A ArbuckleCOOSell8,603$349.00$3,002,447.00 5/30/2023Kristen AmbroseCAOSell289$329.82$95,317.98 5/30/2023Stuart A ArbuckleCOOSell82$329.82$27,045.24 5/8/2023Bastiano SannaEVPSell2,850$350.00$997,500.00 5/8/2023Jeffrey M LeidenChairmanSell1,125$349.00$392,625.00 5/5/2023Bastiano SannaEVPSell422$350.03$147,712.66 5/5/2023Jeffrey M LeidenChairmanSell879$349.56$307,263.24 5/2/2023Bastiano SannaEVPSell1,622$350.66$568,770.52 5/2/2023Jeffrey M LeidenChairmanSell6,450$349.89$2,256,790.50 5/2/2023Sangeeta N BhatiaDirectorSell580$348.28$202,002.40 4/27/2023Reshma KewalramaniCEOSell3,317$339.08$1,124,728.36 (Data available from 1/1/2013 forward) VRTX Insider Trading Activity - Frequently Asked Questions Who is on Vertex Pharmaceuticals's Insider Roster? The list of insiders at Vertex Pharmaceuticals includes Amit Sachdev, Bastiano Sanna, Bruce I Sachs, Carmen Bozic, Charles F Wagner Jr, David Altshuler, Jeffrey M Leiden, Jonathan Biller, Joy Liu, Kristen Ambrose, Lloyd Carney, Margaret G Mcglynn, Ourania Tatsis, Reshma Kewalramani, Sangeeta N Bhatia, Stuart A Arbuckle, and Yuchun Lee. Learn more on insiders at VRTX. What percentage of Vertex Pharmaceuticals stock is owned by insiders? 0.20% of Vertex Pharmaceuticals stock is owned by insiders. Learn more on VRTX's insider holdings. Which Vertex Pharmaceuticals insiders have been selling company stock? The following insiders have sold VRTX shares in the last 24 months: Amit Sachdev ($1,354,013.28), Bastiano Sanna ($5,807,084.69), Bruce I Sachs ($15,304,036.50), Carmen Bozic ($8,055,217.95), Charles F Wagner Jr ($2,609,526.99), David Altshuler ($5,972,384.50), Jeffrey M Leiden ($48,869,051.68), Jonathan Biller ($211,523.60), Joy Liu ($1,455,562.50), Kristen Ambrose ($1,019,800.59), Lloyd Carney ($865,404.00), Ourania Tatsis ($1,842,725.17), Reshma Kewalramani ($14,025,020.40), Sangeeta N Bhatia ($1,202,297.40), Stuart A Arbuckle ($16,979,685.46), and Yuchun Lee ($2,518,290.59). How much insider selling is happening at Vertex Pharmaceuticals? Insiders have sold a total of 405,958 Vertex Pharmaceuticals shares in the last 24 months for a total of $128,091,625.30 sold. Which members of congress are trading Vertex Pharmaceuticals? Greg Stanton (D-AZ) has sold shares of Vertex Pharmaceuticals in the last year totaling $8,000. More Insider Trading Tools from MarketBeat Related Companies: Regeneron Pharmaceuticals Insider Selling Bristol-Myers Squibb Insider Selling Sanofi Insider Selling GSK Insider Selling Zoetis Insider Selling Pfizer Insider Selling Takeda Pharmaceutical Insider Selling Abbott Laboratories Insider Selling Royalty Pharma Insider Selling BeiGene Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Pagaya Technologies: An AI Fintech That Insiders Are BuyingThe 5 Stocks Most Sold By Insiders This Year3 Cheap Stocks Insiders are Buying: Investors Should Avoid 1The 5 Hottest CEO Stock Purchases So Far This Year3 Cheap Stocks that Insiders Bought in Q1 This page (NASDAQ:VRTX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithMan Who Predicted 2008: “This Will be Worse.”AltimetryWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.